Vijaya Diagnostic Q2 FY27 standalone revenue Rs 242.00 cr, PAT Rs 57.92 cr
For Q2 FY27, Vijaya Diagnostic Centre standalone revenue from operations was Rs 242.00 cr and profit after tax Rs 57.92 cr, up from Q2 FY26.
Key takeaways
- Revenue from operations in Q2 FY27 was Rs 242.00 cr vs Rs 189.96 cr in Q2 FY26.
- Total income in Q2 FY27 was Rs 247.45 cr vs Rs 195.13 cr a year earlier.
- PAT in Q2 FY27 was Rs 57.92 cr vs Rs 42.98 cr in Q2 FY26.
- Total expenses in Q2 FY27 were Rs 169.52 cr vs Rs 137.67 cr in Q2 FY26.
- Basic EPS for Q2 FY27 was Rs 5.63 vs Rs 4.18 in Q2 FY26.
Q2 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 242.00 cr | Rs 189.96 cr | +27.4% |
| PAT | Rs 57.92 cr | Rs 42.98 cr | +34.8% |
| EPS | Rs 5.63 | Rs 4.18 | +34.7% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 23.93% of revenue, up 130 bps from 22.63%.
- Revenue rose 27.4% while total expenses rose 23.1%.
- Other expenses accounted for Rs 13.10 cr of the Rs 31.85 cr rise in total expenses (41%).
- Other expenses took 29.5% of revenue, against 30.7% a year earlier.
Key standalone numbers (statement of financial results)
- Revenue from operations (Q2 FY27): Rs 242.00 cr (Q2 FY26: Rs 189.96 cr)
- Total income (Q2 FY27): Rs 247.45 cr (Q2 FY26: Rs 195.13 cr)
- Total expenses (Q2 FY27): Rs 169.52 cr (Q2 FY26: Rs 137.67 cr)
- Cost of materials consumed (Q2 FY27): Rs 27.22 cr (Q2 FY26: Rs 22.67 cr)
- Employee benefits expense (Q2 FY27): Rs 35.98 cr (Q2 FY26: Rs 29.98 cr)
- Finance costs (Q2 FY27): Rs 10.82 cr (Q2 FY26: Rs 7.21 cr)
- Depreciation and amortisation expense (Q2 FY27): Rs 23.99 cr (Q2 FY26: Rs 19.40 cr)
- Other expenses (Q2 FY27): Rs 71.51 cr (Q2 FY26: Rs 58.41 cr)
- Profit before tax – PBT (Q2 FY27): Rs 77.93 cr (Q2 FY26: Rs 57.47 cr)
- Profit for the period – PAT (Q2 FY27): Rs 57.92 cr (Q2 FY26: Rs 42.98 cr)
- Basic EPS (Q2 FY27): Rs 5.63 (Q2 FY26: Rs 4.18)
- Diluted EPS (Q2 FY27): Rs 5.61 (Q2 FY26: Rs 4.17)
For the year-to-date period ended 30 September 2026, the standalone statement of financial results shows revenue from operations of Rs 460.54 cr and total income of Rs 475.01 cr, compared with revenue from operations of Rs 367.33 cr and total income of Rs 379.76 cr for the year-to-date period ended 30 September 2025 (as per the statement of financial results).
Year-to-date total expenses were Rs 326.17 cr versus Rs 269.77 cr a year earlier. Within this, cost of materials consumed was Rs 51.54 cr (prior year-to-date: Rs 42.86 cr), employee benefits expense Rs 70.88 cr (prior: Rs 59.45 cr), finance costs Rs 21.24 cr (prior: Rs 14.13 cr), depreciation and amortisation expense Rs 46.32 cr (prior: Rs 37.76 cr) and other expenses Rs 136.19 cr (prior: Rs 115.58 cr).
Profit before tax for the year-to-date period ended 30 September 2026 was Rs 148.84 cr, compared with Rs 110.00 cr for the corresponding year-to-date period ended 30 September 2025. Profit for the period (profit after tax) for the year-to-date period ended 30 September 2026 was Rs 111.07 cr, against Rs 82.03 cr for the year-to-date period ended 30 September 2025.
According to the statement of financial results, basic earnings per equity share (face value Re. 1 each, not annualised) for the year-to-date period ended 30 September 2026 was Rs 10.79, compared with Rs 7.98 for the year-to-date period ended 30 September 2025. Diluted earnings per equity share (not annualised) for the same periods were Rs 10.77 and Rs 7.96 respectively.
Track Vijaya Diagnostic Centre Ltd
Cruxal reads every Vijaya Diagnostic Centre Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
